| Literature DB >> 29041953 |
Penny Whiting1,2, Robert Wolff3, Susan Mallett4,5, Iveta Simera6, Jelena Savović7,8.
Abstract
BACKGROUND: Assessment of the quality of included studies is an essential component of any systematic review. A formal quality assessment is facilitated by using a structured tool. There are currently no guidelines available for researchers wanting to develop a new quality assessment tool.Entities:
Keywords: Quality; Risk of bias; Systematic reviews
Mesh:
Year: 2017 PMID: 29041953 PMCID: PMC5646161 DOI: 10.1186/s13643-017-0604-6
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Fig. 1Overview of proposed framework
Proposed steps to develop QA tools with examples drawn from existing tool development
| Stage | QUADAS-2[ | ROBIS [ | PROBAST [ | ROBINS-I [ | RoB 2.0 [ |
|---|---|---|---|---|---|
| Stage 1: initial steps | |||||
| 1.1 Identify need | Update for QUADAS | New tool specifically for RoB in SR | New tool specifically for prediction models | New tool specifically for NRS of interventions | Update to Cochrane RoB tool |
| 1.2 Obtain funding | Part of MRC methodology programme grant | MRC methodology project grant | No external funding | MIF grant from Cochrane and MRC methodology project grant | MRC hubs project grant |
| 1.3 Assemble team | Larger group ( | Steering group ( | Larger group ( | Domain-based working groups and others ( | Domain-based working groups and others ( |
| 1.4 Manage project | Steering group ( | Project group ( | Steering group ( | Steering group ( | Steering group ( |
| 1.5 Define scope | Diagnostic test accuracy | Systematic reviews | Prediction modelling (prognostic and diagnostic) | Non-randomised studies of interventions | Randomised controlled trials |
| Bias + applicability | Bias + relevance | Bias + applicability | Bias | Bias | |
| Stage 2: tool development | |||||
| 2.1. Generate items | Starting point original QUADAS tool [ | Review of existing QA tools + how QA handled in existing overviews | Key publications on prognostic modelling studies | Survey of Cochrane review groups and face-to-face meeting. Domain-based working groups | Starting point draft tool based on original Cochrane RoB [ |
| 2.2. Agree items | Face-to-face meeting | Face-to-face meeting | Web-based survey | Face-to-face meeting + domain-based working group | Face-to-face meeting + domain-based working group |
| 2.3. Produce first draft | Steering group | Steering group | Steering group | Domain-based working groups + steering group | Domain-based working groups + steering group |
| 2.4. Pilot and refine | Web-based survey + piloting in reviews | Web-based survey + piloting in reviews and by steering group members on key reviews | Web-based survey + piloting in reviews | Domain-based working groups, web survey, cognitive interviews, piloting by working groups and external reviewers on key papers, event to pilot version 1.0 | Domain-based working groups + 3 day piloting event + additional piloting of refined version |
| Stage 3: Dissemination | |||||
| 3.1 Publication | Single publication + guidance document as web supplement | Single publication + guidance document as web supplement | Primary publication + E&E document (in process) | Single publication + guidance document on website | Not yet published, guidance document on website |
| 3.2 Website |
|
| Not yet available |
|
|
| 3.3 Uptake | Recommended by multiple organisations including Cochrane, NICE and AHRQ, | Recommended by Cochrane, NICE and Estonia Health Insurance Fund | Recommended by Cochrane Prognosis Group | Not yet, only recently available | Not yet, only recently available |
| 3.4 Translations | Italian and Japanese versions | Estonian and Portuguese versions in preparation | None to date | None to date | None to date |
Question to consider when defining the scope
| ● What study designs will be targeted by the new tool? |
| ● Will the tool consider only risk of bias (internal validity) or will it also be concerned with assessing applicability (external validity) and possibly reporting quality? |
| ● What is the definition of quality for the tool? How is risk of bias defined? How are other components of quality defined (if included), e.g. applicability? |
| ● What type of tool structure will be adopted, e.g. simple checklist design or a domain-based approach? |
| ● How will quality items be rated within the tool? |